RevitaCare Dynamics
About
A global early-stage investor focused on precision health, diagnostics, and transformative medical technologies.
Investment Approach
RevitaCare Dynamics identifies and invests in early-stage companies that are solving medicine's most complex challenges through technological disruption. We believe the future of healthcare lies in precision, prediction, and automation.
-
Precision Medicine & Diagnostics: Companies leveraging AI, multi-omics, and biomarker discovery to move from reactive care to proactive, personalized health management.
-
Medical Robotics & Automation: Intelligent systems that enhance surgical precision, rehabilitative therapy, and clinical workflows.
-
Digital Health Infrastructure: Enabling technologies that form the backbone of next-generation clinical decision support and care delivery.
Portfolio
Genetic Population Health
Enables Caribbean population genomics and precision medicine
Cardiovascular Diagnostics
Faster, lower-cost triage of coronary artery disease in Emergency Departments
Precision Oncology
Improves accuracy of treatment selection for cancer patients
Medical Robotics
Precise, intuitive control over robotic operations and automated systems
Founder
Marlon Thompson, Ph.D., is a seasoned healthcare executive with a passion for driving innovation in medical diagnostics and improving patient care. With over two decades of experience in leading global businesses and driving innovation in medical diagnostics and life sciences, he has held leadership positions at prominent companies including Abbott Laboratories, Royal Philips, Leica Biosystems, and Siemens Healthcare Diagnostics.
Dr. Thompson's career highlights include leading the commercial launch of the first FDA-approved blood test for mild traumatic brain injury, leading the development of the global clinical Digital Pathology market, and driving strategic acquisitions to expand business portfolios. He has also advised some of the largest global healthcare companies as a McKinsey management consultant. His expertise spans commercial operations, product development, and business strategy, with a particular focus on advancing healthcare through new technology introduction.
​A scientist by training, he holds a Ph.D. in Chemistry and has authored multiple patent and peer-reviewed publications. He combines his scientific background with strong business acumen, having earned an MBA from The Wharton School at the University of Pennsylvania. His blend of scientific knowledge and business leadership gives him a unique ability to assess healthcare technologies and support the growth of the companies that develop them.
Contact Us